Notify me when Gates Frontier, LLC files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| LYEL | Lyell Immunopharma, Inc. | Common Stock, $0.0001 par value per share | 5.6% | $10.6M | 1.04M | Gates Frontier, LLC | 25 Jul 2025 | ||
| EVLV | Evolv Technologies Holdings, Inc. | Class A common stock, par value $0.0001 per share | 1.4% | $19.8M | 2.37M | Gates Frontier, LLC | 18 Sep 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|